(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of NXP Semiconductors NXPI, Walgreens Boots WBA and others.
Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.
Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.
Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.
In the next session, Via News will report the finding on the algorithm precision.
| Financial Asset | Accuracy | Close Price | Prediction |
|---|---|---|---|
| NXP Semiconductors (NXPI) | 94% | $211.81 | ⇧ $212.5 |
| Walgreens Boots (WBA) | 93.93% | $30.3 | ⇧ $30.44 |
| Ford (F) | 93.39% | $15.27 | ⇧ $15.74 |
| Archer (ADM) | 93.05% | $78.78 | ⇧ $81.67 |
| Mastercard (MA) | 89.65% | $400.54 | ⇧ $401.95 |
| General Motors (GM) | 89.53% | $40.67 | ⇧ $40.93 |
| Trip.com (TCOM) | 89.26% | $37.17 | ⇧ $37.51 |
| Spotify (SPOT) | 89.26% | $165.75 | ⇧ $166.23 |
| Marriott International (MAR) | 88.98% | $190.81 | ⇧ $191.48 |
| Magna International (MGA) | 88.93% | $59.43 | ⇧ $61.04 |
| DexCom (DXCM) | 88.93% | $133.68 | ⇧ $134.08 |
| Visa (V) | 88.9% | $242.5 | ⇧ $244.64 |
| Amgen (AMGN) | 88.72% | $225.68 | ⇧ $228.91 |
| Baidu (BIDU) | 88.7% | $148.76 | ⇧ $149.2 |
| Alnylam Pharmaceuticals (ALNY) | 88.64% | $202.57 | ⇧ $205.77 |
| Credit Acceptance Corporation (CACC) | 88.53% | $537.15 | ⇧ $548.98 |
| American Express (AXP) | 88.49% | $174.55 | ⇧ $179.14 |
| Biogen (BIIB) | 88.45% | $277.63 | ⇧ $285.26 |
| Skyworks Solutions (SWKS) | 87.91% | $112.82 | ⇧ $116.66 |
| QuantumScape (QS) | 87.76% | $10.19 | ⇧ $10.26 |
| Tyson Foods (TSN) | 87.74% | $52.08 | ⇧ $53.72 |
| IDEXX Laboratories (IDXX) | 87.7% | $525.84 | ⇧ $543.79 |
| Pepsico (PEP) | 87.64% | $183.41 | ⇧ $186.79 |
| Splunk (SPLK) | 84.57% | $103.61 | ⇧ $104.57 |
| The AES (AES) | 84.33% | $21.65 | ⇧ $22.07 |
| Quidel (QDEL) | 84.3% | $87.32 | ⇧ $89.15 |
| Phillips 66 (PSX) | 84.27% | $101.9 | ⇧ $102.3 |
| NewMarket (NEU) | 84.19% | $429.22 | ⇧ $437.06 |
1. NXP Semiconductors (NXPI)
Shares of NXP Semiconductors rose 7.26% in from $197.47 to $211.81 at 19:21 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two consecutive sessions in a row of gains.
NXP Semiconductors N.V. offers various semiconductor products. The company's product portfolio includes microcontrollers; application processors, including i.MX application processors, and i.MX 8 and 9 family of applications processors; communication processors; wireless connectivity solutions, such as near field communications, ultra-wideband, Bluetooth low-energy, Zigbee, and Wi-Fi and Wi-Fi/Bluetooth integrated SoCs; analog and interface devices; radio frequency power amplifiers; and security controllers, as well as semiconductor-based environmental and inertial sensors, including pressure, inertial, magnetic, and gyroscopic sensors. The company's products are used in various applications, including automotive, industrial and Internet of Things, mobile, and communication infrastructure. The company markets its products to various original equipment manufacturers, contract manufacturers, and distributors. It operates in China, the Netherlands, the United States, Singapore, Germany, Japan, South Korea, Taiwan, and internationally. The company was formerly known as KASLION Acquisition B.V and changed its name to NXP Semiconductors N.V. in May 2010. NXP Semiconductors N.V. was incorporated in 2006 and is headquartered in Eindhoven, the Netherlands.
Yearly Top and Bottom Value
NXP Semiconductors’s stock is valued at $211.81 at 19:21 EST, higher than its 52-week high of $208.63.
More news about NXP Semiconductors.
2. Walgreens Boots (WBA)
Shares of Walgreens Boots fell 5.35% in from $32.01 to $30.30 at 19:21 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two successive sessions in a row of gains.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Moving Average
Walgreens Boots’s worth is below its 50-day moving average of $31.82 and way below its 200-day moving average of $35.11.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Walgreens Boots’s stock is considered to be oversold (<=20).
Volatility
Walgreens Boots’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.11%, a negative 0.20%, and a positive 1.45%.
Walgreens Boots’s highest amplitude of average volatility was 1.39% (last week), 1.88% (last month), and 1.45% (last quarter).
Sales Growth
Walgreens Boots’s sales growth for the current quarter is 6.5%.
More news about Walgreens Boots.
3. Ford (F)
Shares of Ford rose 8.07% in from $14.13 to $15.27 at 19:21 EST on Wednesday, after three successive sessions in a row of gains. NYSE is rising 0.72% to $16,011.28, after three sequential sessions in a row of gains.
Ford Motor Company develops, delivers, and services a range of Ford trucks, commercial cars and vans, sport utility vehicles, and Lincoln luxury vehicles worldwide. It operates through Ford Blue, Ford Model e, and Ford Pro; Ford Next; and Ford Credit segments. The company sells Ford and Lincoln vehicles, service parts, and accessories through distributors and dealers, as well as through dealerships to commercial fleet customers, daily rental car companies, and governments. It also engages in vehicle-related financing and leasing activities to and through automotive dealers. In addition, the company provides retail installment sale contracts for new and used vehicles; and direct financing leases for new vehicles to retail and commercial customers, such as leasing companies, government entities, daily rental companies, and fleet customers. Further, it offers wholesale loans to dealers to finance the purchase of vehicle inventory; and loans to dealers to finance working capital and enhance dealership facilities, purchase dealership real estate, and other dealer vehicle programs. The company was incorporated in 1903 and is based in Dearborn, Michigan.
More news about Ford.
4. Archer (ADM)
Shares of Archer rose 5.99% in from $74.33 to $78.78 at 19:21 EST on Wednesday, after three successive sessions in a row of gains. NYSE is rising 0.72% to $16,011.28, after three consecutive sessions in a row of gains.
Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. The company operates in three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. It originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds. The company also engages in the agricultural commodity and feed product import, export, and distribution; and structured trade finance activities. In addition, it offers vegetable oils and protein meals; ingredients for the food, feed, energy, and industrial customers; crude vegetable oils, salad oils, margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products. Further, the company provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; and citric acids. Additionally, the company provides natural flavors, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and foods. It also offers futures commission merchant; commodity brokerage services; cash margins and securities pledged to commodity exchange clearinghouses; and cash pledged as security under certain insurance arrangements. The company was founded in 1902 and is headquartered in Chicago, Illinois.
Yearly Top and Bottom Value
Archer’s stock is valued at $78.78 at 19:21 EST, way under its 52-week high of $98.28 and way higher than its 52-week low of $69.92.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 26.5% and a negative 17.2%, respectively.
More news about Archer.
5. Mastercard (MA)
Shares of Mastercard jumped 8.13% in from $370.42 to $400.54 at 19:21 EST on Wednesday, after three successive sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three successive sessions in a row of gains.
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; payment products and solutions that allow its customers to access funds in deposit and other accounts; prepaid programs services; and commercial credit, debit, and prepaid payment products and solutions. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 14.5% and 20.9%, respectively.
Previous days news about Mastercard
- Mastercard (ma) & jazzcash to speed up digitization in Pakistan. According to Zacks on Tuesday, 11 July, "This move builds on the existing partnership of JazzCash and Mastercard and aims to drive financial inclusion in the country. ", "Shares of Mastercard have gained 21.5% in a year compared with theindustry’s 10.1% growth."
More news about Mastercard.
6. General Motors (GM)
Shares of General Motors jumped 7.96% in from $37.67 to $40.67 at 19:21 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three successive sessions in a row of gains.
General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. The company also sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. In addition, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties; and safety and security services for retail and fleet customers, including automatic crash response, emergency services, roadside assistance, crisis assist, stolen vehicle assistance, and turn-by-turn navigation. Further, the company provides connected services comprising mobile applications for owners to remotely control their vehicles and electric vehicle owners to locate charging stations, on-demand vehicle diagnostics, GM Smart Driver, Amazon Alexa in-vehicle voice, Google's Voice Assistant, navigation and app ecosystem, connected navigation, SiriusXM with 360L, and 4G LTE wireless connectivity. Additionally, the company provides automotive financing and insurance services; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.
Yearly Top and Bottom Value
General Motors’s stock is valued at $40.67 at 19:21 EST, under its 52-week high of $43.63 and way higher than its 52-week low of $30.36.
Moving Average
General Motors’s value is way above its 50-day moving average of $34.92 and way higher than its 200-day moving average of $36.47.
More news about General Motors.
7. Trip.com (TCOM)
Shares of Trip.com jumped 2.62% in from $36.22 to $37.17 at 19:21 EST on Wednesday, after three sequential sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two successive sessions in a row of gains.
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
Yearly Top and Bottom Value
Trip.com’s stock is valued at $37.17 at 19:21 EST, under its 52-week high of $40.17 and way above its 52-week low of $19.25.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 1350% and 152.2%, respectively.
More news about Trip.com.
8. Spotify (SPOT)
Shares of Spotify rose 9.58% in from $151.26 to $165.75 at 19:21 EST on Wednesday, after five consecutive sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three sequential sessions in a row of gains.
Spotify Technology S.A., together with its subsidiaries, provides audio streaming services worldwide. It operates through two segments, Premium and Ad-Supported. The Premium segment offers unlimited online and offline streaming access to its catalog of music and podcasts without commercial breaks to its subscribers. The Ad-Supported segment provides on-demand online access to its catalog of music and unlimited online access to the catalog of podcasts to its subscribers on their computers, tablets, and compatible mobile devices. The company also offers sales, distribution and marketing, contract research and development, and customer support services. Spotify Technology S.A. was incorporated in 2006 and is based in Luxembourg, Luxembourg.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Spotify’s stock is considered to be oversold (<=20).
Sales Growth
Spotify’s sales growth is 19.5% for the current quarter and 14.9% for the next.
Volatility
Spotify’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.71%, a positive 0.25%, and a positive 1.51%.
Spotify’s highest amplitude of average volatility was 1.04% (last week), 1.30% (last month), and 1.51% (last quarter).
More news about Spotify.
9. Marriott International (MAR)
Shares of Marriott International jumped 5.53% in from $180.81 to $190.81 at 19:21 EST on Wednesday, after three consecutive sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two successive sessions in a row of gains.
What makes marriott international (mar) a strong momentum stock: buy now?Taking into account all of these elements, it should come as no surprise that MAR is a #2 (Buy) stock with a Momentum Score of A. If you’ve been searching for a fresh pick that’s set to rise in the near-term, make sure to keep Marriott International on your short list., Over the past quarter, shares of Marriott International have risen 10.14%, and are up 37.48% in the last year.
Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide. The company operates through U.S. and Canada, and International segments. It operates its properties under the JW Marriott, The Ritz-Carlton, Ritz-Carlton Reserve, W Hotels, The Luxury Collection, St. Regis, EDITION, Bvlgari, Renaissance, Le Méridien, Marriott, Sheraton, Westin, Four Points, Delta Hotels by Marriott, Autograph Collection, Tribute Portfolio, Marriott Hotels, Marriott Executive Apartments, Marriott Vacation Club, Gaylord Hotels, Design Hotels, Courtyard, Residence Inn, Fairfield, SpringHill Suites, TownePlace Suites, Protea Hotels, Aloft Hotels, AC Hotels by Marriott, Element Hotels, and Moxy Hotels brand names. It operates properties under 30 brand names in 138 countries and territories. Marriott International, Inc. was founded in 1927 and is headquartered in Bethesda, Maryland.
Yearly Top and Bottom Value
Marriott International’s stock is valued at $190.81 at 19:21 EST, higher than its 52-week high of $187.12.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 20.6% and 19.5%, respectively.
More news about Marriott International.
10. Magna International (MGA)
Shares of Magna International jumped 6.14% in from $55.99 to $59.43 at 19:21 EST on Wednesday, after two successive sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three sequential sessions in a row of gains.
Magna International Inc. designs, engineers, and manufactures components, assemblies, systems, subsystems, and modules for original equipment manufacturers of vehicles and light trucks worldwide. It operates through four segments: Body Exteriors & Structures, Power & Vision, Seating Systems, and Complete Vehicles. The Body Exteriors & Structures segment provides body and chassis, exterior, and roof systems, as well as battery enclosures and engineering and testing services, including fascia and trims, front end modules, integration panels, liftgate modules, active aerodynamics, engineered glass, running boards, truck bed access products, breakthrough lightings, quarter windows, encapsulated glasses, and side doors. The Power & Vision segment offers ?electric drive systems and components, such as emotors, inverters, onboard chargers, gearboxes, and e-clutch; dedicated hybrid drives, dual and hybrid dual clutch, and manual transmissions; AWD/4WD products and rear drive modules; transmission, driveline components, and ICE; engineering services; advanced driver assistance systems sensors and, and electronic control units; interior and exterior mirrors, camera and driver monitoring systems and electronics, actuators, door handles, and overhead consoles; forward, rear, and auxiliary lighting products; latching, door modules, window, power closure, and hinges and wire forming systems; and modular and textile folding roofs, and hard and soft tops. The Seating Systems segment provides seat structures, mechanism and hardware solutions, and foam and trim products. The Complete Vehicles segment offers vehicle engineering and manufacturing services. The company also designs, engineers, and manufactures tooling products. Magna International Inc. was founded in 1957 and is headquartered in Aurora, Canada.
More news about Magna International.
11. DexCom (DXCM)
Shares of DexCom rose 5.56% in from $126.64 to $133.68 at 19:21 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ is jumping 1.15% to $13,918.96, after two consecutive sessions in a row of gains.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 35.3% and 14.3%, respectively.
Yearly Top and Bottom Value
DexCom’s stock is valued at $133.68 at 19:21 EST, under its 52-week high of $134.14 and way higher than its 52-week low of $73.93.
More news about DexCom.
12. Visa (V)
Shares of Visa jumped 8.79% in from $222.91 to $242.50 at 19:21 EST on Wednesday, after four sequential sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three consecutive sessions in a row of gains.
Visa Inc. operates as a payments technology company worldwide. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, click to pay; Visa Direct, a real-time payments network; Visa B2B Connect, a multilateral B2B cross-border payments network; Visa Treasury as a Service, a cross-border consumer payments business; and Visa DPS that provides a range of value added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. Further, the; company provides Cybersource, a payment management platform; and risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Advanced Identity Score, and Visa Consumer Authentication Service; and Visa Consulting and Analytics, a payments consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, VPAY, and PLUS brands. The company serves consumers, merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California.
Volatility
Visa’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.18%, a positive 0.29%, and a positive 0.85%.
Visa’s highest amplitude of average volatility was 0.66% (last week), 0.85% (last month), and 0.85% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 7.1% and 16.1%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 30.98B for the twelve trailing months.
More news about Visa.
13. Amgen (AMGN)
Shares of Amgen jumped 1.92% in from $221.43 to $225.68 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is rising 1.15% to $13,918.96, after two consecutive sessions in a row of gains.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Moving Average
Amgen’s value is below its 50-day moving average of $226.20 and below its 200-day moving average of $247.15.
Volatility
Amgen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.22%, a positive 0.16%, and a positive 0.93%.
Amgen’s highest amplitude of average volatility was 1.61% (last week), 1.06% (last month), and 0.93% (last quarter).
Yearly Top and Bottom Value
Amgen’s stock is valued at $225.68 at 19:21 EST, way under its 52-week high of $296.67 and above its 52-week low of $211.71.
More news about Amgen.
14. Baidu (BIDU)
Shares of Baidu rose 3.9% in from $143.18 to $148.76 at 19:21 EST on Wednesday, after three consecutive sessions in a row of gains. NASDAQ is jumping 1.15% to $13,918.96, after two successive sessions in a row of gains.
Baidu, Inc. offers internet search services in China. It operates through Baidu Core and iQIYI segments. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app. It also provides Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Experience; Baidu Post; Baidu Wenku; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, it offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Further, the company provides iQIYI, an online entertainment service, including original and licensed content; other video content and membership; and online advertising services. Baidu, Inc. has strategic partnership with Zhejiang Geely Holding Group. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
Sales Growth
Baidu’s sales growth is 12.4% for the ongoing quarter and 3.4% for the next.
Volatility
Baidu’s last week, last month’s, and last quarter’s current intraday variation average was 0.25%, 0.35%, and 2.29%.
Baidu’s highest amplitude of average volatility was 1.60% (last week), 2.24% (last month), and 2.29% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Baidu’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 11% and 2.4%, respectively.
More news about Baidu.
15. Alnylam Pharmaceuticals (ALNY)
Shares of Alnylam Pharmaceuticals jumped 2.41% in from $197.8 to $202.57 at 19:21 EST on Wednesday, after two sequential sessions in a row of gains. NASDAQ is jumping 1.15% to $13,918.96, after two successive sessions in a row of gains.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Volatility
Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 1.23%, 0.25%, and 1.52%.
Alnylam Pharmaceuticals’s highest amplitude of average volatility was 1.68% (last week), 1.58% (last month), and 1.52% (last quarter).
Yearly Top and Bottom Value
Alnylam Pharmaceuticals’s stock is valued at $202.57 at 19:21 EST, way below its 52-week high of $242.97 and way higher than its 52-week low of $135.46.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 33.2% and 53%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 49.7%, now sitting on 1.14B for the twelve trailing months.
More news about Alnylam Pharmaceuticals.
16. Credit Acceptance Corporation (CACC)
Shares of Credit Acceptance Corporation rose 5.76% in from $507.9 to $537.15 at 19:21 EST on Wednesday, after four sequential sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two consecutive sessions in a row of gains.
Credit Acceptance Corporation engages in the provision of financing programs, and related products and services to independent and franchised automobile dealers in the United States. The company advances money to automobile dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps the amount collected from the consumers. It is also involved in the business of reinsuring coverage under vehicle service contracts sold to consumers by dealers on vehicles financed by the company. The company was incorporated in 1972 and is headquartered in Southfield, Michigan.
Yearly Top and Bottom Value
Credit Acceptance Corporation’s stock is valued at $537.15 at 19:21 EST, way below its 52-week high of $617.44 and way higher than its 52-week low of $358.00.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 3% and 27%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 33.8%, now sitting on 1.05B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Credit Acceptance Corporation’s stock is considered to be oversold (<=20).
More news about Credit Acceptance Corporation.
17. American Express (AXP)
Shares of American Express slid 0.44% in from $175.32 to $174.55 at 19:21 EST on Wednesday, after two sequential sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three successive sessions in a row of gains.
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Volatility
American Express’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.24%, a positive 0.07%, and a positive 1.16%.
American Express’s highest amplitude of average volatility was 1.38% (last week), 0.82% (last month), and 1.16% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, American Express’s stock is considered to be oversold (<=20).
Sales Growth
American Express’s sales growth is 15.5% for the ongoing quarter and 15% for the next.
More news about American Express.
18. Biogen (BIIB)
Shares of Biogen fell 9.95% in from $308.31 to $277.63 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is jumping 1.15% to $13,918.96, after two sequential sessions in a row of gains.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Yearly Top and Bottom Value
Biogen’s stock is valued at $277.63 at 19:21 EST, way below its 52-week high of $319.76 and way higher than its 52-week low of $193.65.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 28.6% and a negative 14.9%, respectively.
Previous days news about Biogen
- : biogen shares ‘an under-owned turnaround story,’ jefferies analysts say. According to MarketWatch on Monday, 10 July, "Shares of Biogen Inc. , which last week received a milestone U.S. Food and Drug Administration approval for Alzheimer’s treatment Leqembi, "remain an under-owned turnaround story," and the stock should benefit as sales gradually ramp up, Jefferies analysts wrote in a research note Sunday.", "The approval failed to give Biogen stock an immediate boost, as some analysts predicted a slow rollout for Leqembi and bottlenecks at infusion-therapy centers. "
- Biogen (biib) stock down despite FDA nod to alzheimer's drug. According to Zacks on Monday, 10 July, "On Thursday, the FDA had granted traditional approval to Biogen and partner Eisai’s Leqembi, an anti-amyloid beta protofibril antibody drug, for the treatment of AD. "
More news about Biogen.
19. Skyworks Solutions (SWKS)
Shares of Skyworks Solutions jumped 2.7% in from $109.85 to $112.82 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is jumping 1.15% to $13,918.96, after two consecutive sessions in a row of gains.
Skyworks Solutions, Inc., together with its subsidiaries, designs, develops, manufactures, and markets proprietary semiconductor products in the United States, China, South Korea, Taiwan, Europe, the Middle East, Africa, and the rest of Asia-Pacific. Its product portfolio includes amplifiers, antenna tuners, attenuators, automotive tuners and digital radios, clocks and timings, circulators/isolators, DC/DC converters, demodulators, detectors, diodes, wireless analog system on chip products, directional couplers, diversity receive modules, filters, front-end modules, hybrids, light emitting diode drivers, low noise amplifiers, mixers, modulators, optocouplers/optoisolators, phase locked loops, phase shifters, power dividers/combiners, receivers, switches, synthesizers, timing devices, technical ceramics, voltage controlled oscillators/synthesizers, and voltage regulators. The company provides its products for the usage in aerospace, automotive, broadband, cellular infrastructure, connected home, entertainment and gaming, industrial, medical, military, smartphone, tablet, and wearable markets. It sells its products through direct sales force, electronic component distributors, and independent sales representatives. Skyworks Solutions, Inc. was founded in 1962 and is based in Irvine, California.
Sales Growth
Skyworks Solutions’s sales growth is negative 13.2% for the current quarter and negative 13% for the next.
Moving Average
Skyworks Solutions’s value is above its 50-day moving average of $104.39 and way higher than its 200-day moving average of $101.66.
Revenue Growth
Year-on-year quarterly revenue growth declined by 13.7%, now sitting on 5.12B for the twelve trailing months.
Yearly Top and Bottom Value
Skyworks Solutions’s stock is valued at $112.82 at 19:21 EST, under its 52-week high of $123.69 and way higher than its 52-week low of $76.16.
More news about Skyworks Solutions.
20. QuantumScape (QS)
Shares of QuantumScape jumped by a staggering 36.78% in from $7.45 to $10.19 at 19:21 EST on Wednesday, after five sequential sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three sequential sessions in a row of gains.
QuantumScape Corporation, a development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. QuantumScape Corporation was founded in 2010 and is headquartered in San Jose, California.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, QuantumScape’s stock is considered to be oversold (<=20).
More news about QuantumScape.
21. Tyson Foods (TSN)
Shares of Tyson Foods jumped 3.62% in from $50.26 to $52.08 at 19:21 EST on Wednesday, after two successive sessions in a row of gains. NYSE is rising 0.72% to $16,011.28, after three sequential sessions in a row of gains.
Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and live market hogs; fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully cooked meats; raises and processes chickens into fresh, frozen, and value-added chicken products, including breaded chicken strips, nuggets, patties, and other ready-to-fix or fully cooked chicken parts; and supplies poultry breeding stock. It also manufactures and markets frozen and refrigerated food products, including ready-to-eat sandwiches, flame-grilled hamburgers, Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks, and processed meats under the Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, Aidells, and Gallo Salame brands. In addition, the company offers its products under the Tyson and ibp brands. It sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors who serve restaurants and food service operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors, as well as through independent brokers and trading companies. The company was founded in 1935 and is headquartered in Springdale, Arkansas.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 86.6% and a negative 76.1%, respectively.
Moving Average
Tyson Foods’s value is under its 50-day moving average of $52.91 and way below its 200-day moving average of $60.96.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.1%, now sitting on 53.62B for the twelve trailing months.
Sales Growth
Tyson Foods’s sales growth is 0.9% for the current quarter and 0.2% for the next.
More news about Tyson Foods.
22. IDEXX Laboratories (IDXX)
Shares of IDEXX Laboratories rose by a staggering 12.14% in from $468.91 to $525.84 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is jumping 1.15% to $13,918.96, after two sequential sessions in a row of gains.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Sales Growth
IDEXX Laboratories’s sales growth is 8.6% for the ongoing quarter and 9.9% for the next.
More news about IDEXX Laboratories.
23. Pepsico (PEP)
Shares of Pepsico rose 1.12% in from $181.38 to $183.41 at 19:21 EST on Wednesday, following the last session’s downward trend. NASDAQ is rising 1.15% to $13,918.96, after two sequential sessions in a row of gains.
PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. The company offers its products primarily under the Lay's, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, Aquafina, Emperador, Diet Mountain Dew, Diet Pepsi, Gatorade Zero, Propel, Marias Gamesa, Ruffles, Sabritas, Saladitas, Tostitos, 7UP, Diet 7UP, H2oh!, Manzanita Sol, Mirinda, Pepsi Black, San Carlos, Toddy, Walkers, Chipsy, Kurkure, Sasko, Spekko, White Star, Smith's, Sting, SodaStream, Lubimy Sad, Pepsi, and other brands. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is based in Purchase, New York.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 88.04B for the twelve trailing months.
More news about Pepsico.
24. Splunk (SPLK)
Shares of Splunk jumped 2.15% in from $101.43 to $103.61 at 19:21 EST on Wednesday, after three consecutive sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two successive sessions in a row of gains.
Splunk Inc., together with its subsidiaries, develops and markets cloud services and licensed software solutions in the United States and internationally. The company offers unified security and observability platform, including Splunk Security that helps security leaders fortify their organization's digital resilience by mitigating cyber risk and meeting compliance requirements; and Splunk Observability, which provides visibility across the full stack of infrastructure, applications, and the digital customer experience. It also provides application programming interfaces, software development kits, and other interfaces that enables its network of third-party developers, partners, and customers to build content, including pre-built data inputs, workflows, searches, reports, alerts, custom dashboards, flexible user interface components, custom data visualizations, and integration actions and methods that configures and extends its solutions to accommodate specific use cases. In addition, the company offers adoption and implementation, education, and customer support services. It sells its offerings directly through field and inside sales, and indirectly through various routes to market with various partners. Splunk Inc. was incorporated in 2003 and is headquartered in San Francisco, California.
Moving Average
Splunk’s value is above its 50-day moving average of $96.84 and way above its 200-day moving average of $90.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 3.73B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 400% and a drop 4.8% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Splunk’s stock is considered to be oversold (<=20).
More news about Splunk.
25. The AES (AES)
Shares of The AES jumped 4.74% in from $20.67 to $21.65 at 19:21 EST on Wednesday, following the last session’s upward trend. NYSE is jumping 0.72% to $16,011.28, after three successive sessions in a row of gains.
The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries. The company also owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user customers in the residential, commercial, industrial, and governmental sectors; and generates and sells electricity on the wholesale market. It uses a range of fuels and technologies to generate electricity, including coal, gas, hydro, wind, solar, and biomass; and renewables, such as energy storage and landfill gas. The company owns and/or operates a generation portfolio of approximately 32,326 megawatts. It has operations in the United States, Puerto Rico, El Salvador, Chile, Colombia, Argentina, Brazil, Mexico, Central America, the Caribbean, Europe, and Asia. The company was formerly known as Applied Energy Services, Inc. and changed its name to The AES Corporation in April 2000. The AES Corporation was incorporated in 1981 and is headquartered in Arlington, Virginia.
More news about The AES.
26. Quidel (QDEL)
Shares of Quidel jumped 1.66% in from $85.89 to $87.32 at 19:21 EST on Wednesday, after three sequential sessions in a row of gains. NASDAQ is rising 1.15% to $13,918.96, after two sequential sessions in a row of gains.
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.
More news about Quidel.
27. Phillips 66 (PSX)
Shares of Phillips 66 jumped 4.27% in from $97.73 to $101.90 at 19:21 EST on Wednesday, after four successive sessions in a row of gains. NYSE is jumping 0.72% to $16,011.28, after three successive sessions in a row of gains.
Phillips 66 operates as an energy manufacturing and logistics company in the United States, the United Kingdom, Germany, and internationally. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas. The Chemicals segment produces and markets ethylene and other olefin products; aromatics and styrenics products, such as benzene, cyclohexane, styrene, and polystyrene; and various specialty chemical products, including organosulfur chemicals, solvents, catalysts, and chemicals used in drilling and mining. The Refining segment refines crude oil and other feedstocks into petroleum products, such as gasolines, distillates, aviation, and renewable. The M&S segment purchases for resale and markets refined petroleum products, including gasolines, distillates, and aviation fuels. This segment also manufactures and markets specialty products, such as base oils and lubricants. The company was founded in 1875 and is headquartered in Houston, Texas.
Sales Growth
Phillips 66’s sales growth is negative 29.6% for the ongoing quarter and negative 22% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Phillips 66’s stock is considered to be oversold (<=20).
More news about Phillips 66.
28. NewMarket (NEU)
Shares of NewMarket jumped 5.57% in from $406.57 to $429.22 at 19:21 EST on Wednesday, following the last session’s downward trend. NYSE is rising 0.72% to $16,011.28, after three consecutive sessions in a row of gains.
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 2.81B for the twelve trailing months.
Moving Average
NewMarket’s value is above its 50-day moving average of $399.44 and way above its 200-day moving average of $346.93.
Sales Growth
NewMarket’s sales growth for the next quarter is 2.9%.
Yearly Top and Bottom Value
NewMarket’s stock is valued at $429.22 at 19:21 EST, above its 52-week high of $423.76.
More news about NewMarket.
